SS Innovations International (SSII) Deferred Taxes (2025 - 2026)
SS Innovations International's (SSII) quarterly Deferred Taxes came in at -$35421.0 in Q2 2026, up 88.23% quarter-over-quarter from -$301036.0 in Q1 2026.
Powered by 
Analysis
SS Innovations International (SSII) Deferred Taxes (2025 - 2026) Analysis & Trends
SS Innovations International has disclosed Deferred Taxes across 2 years of filings, most recently posting -$35421.0 for Q2 2026.
- In Q2 2026, Deferred Taxes changed N/A year-over-year to -$35421.0; the TTM figure through Jun 2026 stood at -$483681.0 (changed N/A YoY), while the FY2025 annual figure was -$512865.0, changed N/A from the prior year.
- Deferred Taxes came in at -$35421.0 for Q2 2026 at SS Innovations International, up from -$301036.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $210585.0 in Q3 2025 to a low of -$357809.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -31.00 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 127.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 107.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 17.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | -181.30 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -300,000.00 |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 600,000.00 |
| 10 | SS Innovations International | 682.58 Mn | 660.28 Mn | 7.10 Mn | -35,421.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35,421.00 |
| Mar 31, 2026 | -301,036.00 |
| Dec 31, 2025 | -357,809.00 |
| Sep 30, 2025 | 210,585.00 |